Inactive Ingredient Search for Approved Drug Products

• Share
• Tweet
• Linkedin
• Pin it
• More sharing options
  • Linkedin
  • Pin it
• Email
• Print

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with T

	Quarter	Inactive Ingredient	Route of Administration	Dosage Form	Maximum Potency per unit dose	Maximum Daily Exposure	Status
8961	Q3 2021	TALC	ORAL	TABLET, MULTILAYER, EXTENDED RELEASE		18 mg	Correction
8961	Q4 2021	TALC	ORAL	TABLET, MULTILAYER, EXTENDED RELEASE	9.00 mg		Correction
8952	Q3 2021	TALC	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE	12.00 mg		MDE Replacement
8952	Q4 2021	TALC	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE		18 mg	MDE Replacement
8959	Q3 2021	TALC	ORAL	TABLET, FILM COATED, EXTENDED RELEASE	30.00 mg		MDE Replacement
8959	Q4 2021	TALC	ORAL	TABLET, FILM COATED, EXTENDED RELEASE		60 mg	MDE Replacement
8986	Q3 2021	TARTARIC ACID	ORAL	TABLET, FOR SUSPENSION	7.00 mg		MDE Replacement
8986	Q4 2021	TARTARIC ACID	ORAL	TABLET, FOR SUSPENSION		28 mg	MDE Replacement
9009	Q3 2021	TERT-BUTYLHYDROQUINONE	VAGINAL	CREAM	0.02 %w/w		MDE Replacement
9009	Q4 2021	TERT-BUTYLHYDROQUINONE	VAGINAL	CREAM		0.8 mg	MDE Replacement
9033	Q3 2021	TITANIUM DIOXIDE	BUCCAL	FILM, SOLUBLE	2.78 mg		MDE Replacement
9033	Q4 2021	TITANIUM DIOXIDE	BUCCAL	FILM, SOLUBLE		2.78 mg	MDE Replacement
9051	Q3 2021	TITANIUM DIOXIDE	ORAL	SUSPENSION		75 mg	Correction
9051	Q4 2021	TITANIUM DIOXIDE	ORAL	SUSPENSION		80 mg	Correction
9057	Q3 2021	TITANIUM DIOXIDE	ORAL	TABLET, FILM COATED	24.23 mg		MDE Replacement
9057	Q4 2021	TITANIUM DIOXIDE	ORAL	TABLET, FILM COATED		36 mg	MDE Replacement
9099	Q3 2021	TRIACETIN	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE	1.36 mg		MDE Replacement
9099	Q4 2021	TRIACETIN	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE		2.04 mg	MDE Replacement
9136	Q3 2021	TRIETHYL CITRATE	ORAL	GRANULE, FOR SUSPENSION	6.94 mg		MDE Replacement
9136	Q4 2021	TRIETHYL CITRATE	ORAL	GRANULE, FOR SUSPENSION		6.94 mg	MDE Replacement
9158	Q3 2021	TRISODIUM CITRATE DIHYDRATE	INTRACARDIAC	INJECTION	0.21 %w/v		MDE Replacement
9158	Q4 2021	TRISODIUM CITRATE DIHYDRATE	INTRACARDIAC	INJECTION		18.63 mg	MDE Replacement
9191	Q3 2021	TRISODIUM CITRATE DIHYDRATE	SUBCUTANEOUS	INJECTION	0.63 %w/v		MDE Replacement
9191	Q4 2021	TRISODIUM CITRATE DIHYDRATE	SUBCUTANEOUS	INJECTION		18.63 mg	MDE Replacement
9215	Q3 2021	TROLAMINE	TOPICAL	GEL, METERED	1.00 %w/w		MDE Replacement
9215	Q4 2021	TROLAMINE	TOPICAL	GEL, METERED		19.25 mg	MDE Replacement
9245	Q3 2021	TROMETHAMINE	ORAL	CAPSULE	15.00 mg		MDE Replacement
9245	Q4 2021	TROMETHAMINE	ORAL	CAPSULE		30 mg	MDE Replacement
9204	Q4 2021	TRISODIUM HEDTA	TOPICAL	SPONGE	0.01 %w/w		Deletion
9247	Q4 2021	TROMETHAMINE	ORAL	SOLUTION/ DROPS	7.60 mg/ 1.00 ml		Deletion

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021